Phil, a San Francisco, CA-based software-driven pharmaceutical commercialization platform, obtained $60m development debt financing from K2 HealthVentures (K2HV). The funding…
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
You can revoke your consent any time using the Revoke consent button.